Document Detail


Long-term clinical and echocardiographic follow-up of the freestyle stentless aortic bioprosthesis.
MedLine Citation:
PMID:  22965983     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Stentless aortic bioprostheses were designed to provide enhanced hemodynamic performance and potentially greater longevity. The present report describes the outcomes of patients with the Freestyle stentless bioprosthesis followed for ≤18 years.
METHODS AND RESULTS: Between 1993 and 2011, 430 patients underwent primary aortic valve replacement with a Freestyle bioprosthesis in the subcoronary position. Mean age was 68.2±8.2 years. All of the clinical and echocardiographic data were collected prospectively. Mean overall follow-up was 9.1±4.4 years and was complete in all of the patients. In-hospital mortality was 3.5% (n=15). Overall, 10- and 15-year survival were 60.7% and 35.0%, respectively. Fifty-one patients required reoperation during follow-up, including 27 for structural valve deterioration (SVD). Overall, freedom from reoperation was 91.0% and 75.0% at 10 and 15 years, whereas freedom from reoperation for SVD was 95.9% and 82.3%, respectively. At 10 and 15 years, freedom from reoperation for SVD was 94.0% and 62.6% for patients <60 years of age and 96.3% and 88.4% for patients ≥60 years of age (P=0.002). The median time to explant for SVD was 10.7 years. SVD presented mostly as acute, severe aortic insufficiency attributed to leaflet tear (77.8%). The independent risk factors for reoperation for SVD were age <60 years (P=0.001) and dyslipidemia (P=0.02).
CONCLUSIONS: Aortic valve replacement with the Freestyle bioprosthesis in a subcoronary position provides good long-term clinical and echocardiographic outcomes for patients >60 years of age. Severe aortic insufficiency with leaflet tear is the major mode of SVD leading to reoperation in these patients.
Authors:
Siamak Mohammadi; Vincent Tchana-Sato; Dimitri Kalavrouziotis; Pierre Voisine; Daniel Doyle; Richard Baillot; Sandro Sponga; Jacques Metras; Jean Perron; François Dagenais
Related Documents :
22566463 - Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding a...
23432613 - Avoiding bladder catheterisation in total knee arthroplasty: patient selection criteria...
1680963 - Surgical treatment of tricuspid atresia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Circulation     Volume:  126     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-09-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S198-204     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiac Surgery, Quebec Heart and Lung University Institute, 2725 Chemin Ste-Foy, Quebec City, Quebec, Canada G1V 4G5. siamak.mohammadi@fmed.ulaval.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modulation of transforming growth factor-? signaling and extracellular matrix production in myxomato...
Next Document:  Safe genetic modification of cardiac stem cells using a site-specific integration technique.